Clinical trial · Interventional
Psychosocial Support to Facilitate the Return to Employment of Women With Breast Cancer
Active Early Individualized Psychosocial Accompaniment to Facilitate the Return to Employment of Women With Breast Cancer
NCT01780064CI-TRIAL-00105784APAPIterminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Lack of enrollment
Summary
Brief summary (as posted)
The purpose of this study is to compare the effect of early individualized psychosocial assets versus a standard support on social inequalities in the rate of return to work
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| interviews with a psychologist | Behavioral | — | UNRESOLVED |
| Questionnaires | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Standard group
- description
- routine monitoring with questionnaires
- interventionNames
- Behavioral: Questionnaires
- type
- ACTIVE_COMPARATOR
- label
- Interviews with psychologist
- description
- Patients have interviews with a psychologist (at cure one of chemotherapy treatment,at cure six of chemotherapy treatment, at last radiotherapy session, and three months after the end of radiotherapy) and questionnaires
- interventionNames
- Behavioral: interviews with a psychologist
- Behavioral: Questionnaires
Primary outcomes (1)
- measure
- Comparison of the effect of early individualized psychosocial assets versus a standard support on social inequalities in the rate of return to work
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Women ≥ 18 with work at the time of diagnosis * Presenting a unilateral breast cancer exclusively local extension * Having received surgery * Reporting of adjuvant chemotherapy (+ / - trastuzumab) * Reporting to radiotherapy or not (If radiotherapy, it will be done on site investigator) * In work at the time of diagnosis (employees, traders and professionals) * Patient affiliated to a social security scheme * Consent signed by the patient before the implementation of any specific procedure to study Exclusion Criteria: * Presence of in situ lesions, cancer recurrence, metastatic disease immediately, location bilateral * Inability physical, psychological, psychiatric or cognitive responses to the questionnaires and participate in interviews * Recognition previous ALD (due to another disease) * Patient under guardianship
References
Publications (0)
Data not yet available
No reference posted for this study.